Diluted EPS came in at $-0.99.
Trailing eight quarters through Q2 2024
Common questions about Silexion Therapeutics's Q2 2024 earnings report.
Silexion Therapeutics (SLXN) reported Q2 2024 earnings on August 13, 2024.
Silexion Therapeutics reported diluted EPS of $-0.99 for Q2 2024.
You can read the 10-Q periodic report (0001213900-24-073934) directly on SEC EDGAR. The filing index links above go to sec.gov.